These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
439 related articles for article (PubMed ID: 25728212)
1. Loss of GDF10/BMP3b as a prognostic marker collaborates with TGFBR3 to enhance chemotherapy resistance and epithelial-mesenchymal transition in oral squamous cell carcinoma. Cheng CW; Hsiao JR; Fan CC; Lo YK; Tzen CY; Wu LW; Fang WY; Cheng AJ; Chen CH; Chang IS; Jiang SS; Chang JY; Lee AY Mol Carcinog; 2016 May; 55(5):499-513. PubMed ID: 25728212 [TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor-β1 suppresses bone morphogenetic protein-2-induced mesenchymal-epithelial transition in HSC-4 human oral squamous cell carcinoma cells via Smad1/5/9 pathway suppression. Chiba T; Ishisaki A; Kyakumoto S; Shibata T; Yamada H; Kamo M Oncol Rep; 2017 Feb; 37(2):713-720. PubMed ID: 28035402 [TBL] [Abstract][Full Text] [Related]
3. miR-19a and miR-424 target TGFBR3 to promote epithelial-to-mesenchymal transition and migration of tongue squamous cell carcinoma cells. Li D; Liu K; Li Z; Wang J; Wang X Cell Adh Migr; 2018 May; 12(3):236-246. PubMed ID: 29130787 [TBL] [Abstract][Full Text] [Related]
4. GDF10 inhibits proliferation and epithelial-mesenchymal transition in triple-negative breast cancer via upregulation of Smad7. Zhou T; Yu L; Huang J; Zhao X; Li Y; Hu Y; Lei Y Aging (Albany NY); 2019 May; 11(10):3298-3314. PubMed ID: 31147529 [TBL] [Abstract][Full Text] [Related]
5. Role of SIRT1 in regulation of epithelial-to-mesenchymal transition in oral squamous cell carcinoma metastasis. Chen IC; Chiang WF; Huang HH; Chen PF; Shen YY; Chiang HC Mol Cancer; 2014 Nov; 13():254. PubMed ID: 25424420 [TBL] [Abstract][Full Text] [Related]
6. Loss of RUNX3 expression inhibits bone invasion of oral squamous cell carcinoma. Park J; Kim HJ; Kim KR; Lee SK; Kim H; Park KK; Chung WY Oncotarget; 2017 Feb; 8(6):9079-9092. PubMed ID: 28030842 [TBL] [Abstract][Full Text] [Related]
7. Identification of two distinct carcinoma-associated fibroblast subtypes with differential tumor-promoting abilities in oral squamous cell carcinoma. Costea DE; Hills A; Osman AH; Thurlow J; Kalna G; Huang X; Pena Murillo C; Parajuli H; Suliman S; Kulasekara KK; Johannessen AC; Partridge M Cancer Res; 2013 Jul; 73(13):3888-901. PubMed ID: 23598279 [TBL] [Abstract][Full Text] [Related]
10. GDF10 inhibits cell proliferation and epithelial-mesenchymal transition in nasopharyngeal carcinoma by the transforming growth factor-β/Smad and NF-κB pathways. He F; Feng G; Ma N; Midorikawa K; Oikawa S; Kobayashi H; Zhang Z; Huang G; Takeuchi K; Murata M Carcinogenesis; 2022 Mar; 43(2):94-103. PubMed ID: 34922336 [TBL] [Abstract][Full Text] [Related]
11. Let-7d functions as novel regulator of epithelial-mesenchymal transition and chemoresistant property in oral cancer. Chang CJ; Hsu CC; Chang CH; Tsai LL; Chang YC; Lu SW; Yu CH; Huang HS; Wang JJ; Tsai CH; Chou MY; Yu CC; Hu FW Oncol Rep; 2011 Oct; 26(4):1003-10. PubMed ID: 21725603 [TBL] [Abstract][Full Text] [Related]
12. Neuropilin-1 promotes epithelial-to-mesenchymal transition by stimulating nuclear factor-kappa B and is associated with poor prognosis in human oral squamous cell carcinoma. Chu W; Song X; Yang X; Ma L; Zhu J; He M; Wang Z; Wu Y PLoS One; 2014; 9(7):e101931. PubMed ID: 24999732 [TBL] [Abstract][Full Text] [Related]
14. Overexpression of angiopoietin 2 promotes the formation of oral squamous cell carcinoma by increasing epithelial-mesenchymal transition-induced angiogenesis. Li C; Li Q; Cai Y; He Y; Lan X; Wang W; Liu J; Wang S; Zhu G; Fan J; Zhou Y; Sun R Cancer Gene Ther; 2016 Sep; 23(9):295-302. PubMed ID: 27492854 [TBL] [Abstract][Full Text] [Related]
16. Establishment of 5-fluorouracil-resistant oral squamous cell carcinoma cell lines with epithelial to mesenchymal transition changes. Harada K; Ferdous T; Ueyama Y Int J Oncol; 2014 Apr; 44(4):1302-8. PubMed ID: 24452635 [TBL] [Abstract][Full Text] [Related]
17. Suppression of miR-204 enables oral squamous cell carcinomas to promote cancer stemness, EMT traits, and lymph node metastasis. Yu CC; Chen PN; Peng CY; Yu CH; Chou MY Oncotarget; 2016 Apr; 7(15):20180-92. PubMed ID: 26933999 [TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-β signals promote progression of squamous cell carcinoma by inducing epithelial-mesenchymal transition and angiogenesis. Ibi H; Takahashi K; Harada H; Watabe T; Podyma-Inoue KA Biochem Biophys Res Commun; 2024 Jun; 714():149965. PubMed ID: 38657447 [TBL] [Abstract][Full Text] [Related]
19. Loss of VHL expression contributes to epithelial-mesenchymal transition in oral squamous cell carcinoma. Zhang S; Zhou X; Wang B; Zhang K; Liu S; Yue K; Zhang L; Wang X Oral Oncol; 2014 Sep; 50(9):809-17. PubMed ID: 24998140 [TBL] [Abstract][Full Text] [Related]
20. Tumor-associated macrophages correlate with the clinicopathological features and poor outcomes via inducing epithelial to mesenchymal transition in oral squamous cell carcinoma. Hu Y; He MY; Zhu LF; Yang CC; Zhou ML; Wang Q; Zhang W; Zheng YY; Wang DM; Xu ZQ; Wu YN; Liu LK J Exp Clin Cancer Res; 2016 Jan; 35():12. PubMed ID: 26769084 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]